Bayer Zydus Pharma operates in key segments of the Indian pharmaceuticals market with a strong and successful product list.
This area provides access to press releases and media interaction.
Bayer HealthCare and Zydus Cadila have come together to form a 50:50 joint venture company - Bayer Zydus Pharma in India. Bayer Zydus Pharma combines Bayer HealthCare’s expertise in successfully commercializing novel products, sophisticated administration and sales processes according to international standards, with Zydus Cadila’s strong Indian marketing and sales expertise as well as excellent distribution and industry. Backed by strong research and development and a novel therapeutic approach, Bayer Zydus Pharma is focused on meeting the patients' healthcare needs in India.
Bayer Zydus Pharma operates in key segments of the Indian pharmaceuticals market with a focus on: women’s healthcare, metabolic disorders, diagnostic imaging, cardiovascular diseases, anti-diabetic treatments and oncology.
Bayer Zydus Pharma concentrates its strengths in four business units:
Products from Bayer Zydus Pharma